Sanofi (NASDAQ:SNY) Shares Acquired by Cohen Investment Advisors LLC

Cohen Investment Advisors LLC grew its position in shares of Sanofi (NASDAQ:SNY) by 3.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,271 shares of the company’s stock after purchasing an additional 310 shares during the quarter. Cohen Investment Advisors LLC’s holdings in Sanofi were worth $399,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its holdings in Sanofi by 11.9% in the 2nd quarter. Victory Capital Management Inc. now owns 6,793 shares of the company’s stock worth $330,000 after acquiring an additional 722 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Sanofi by 8.4% in the second quarter. Massachusetts Financial Services Co. MA now owns 141,159 shares of the company’s stock worth $6,849,000 after acquiring an additional 10,941 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Sanofi by 0.4% during the second quarter. Dimensional Fund Advisors LP now owns 318,760 shares of the company’s stock worth $15,466,000 after purchasing an additional 1,238 shares in the last quarter. Moors & Cabot Inc. raised its stake in Sanofi by 14.1% in the 2nd quarter. Moors & Cabot Inc. now owns 8,288 shares of the company’s stock valued at $402,000 after purchasing an additional 1,026 shares during the last quarter. Finally, Argent Trust Co lifted its holdings in Sanofi by 11.7% in the 2nd quarter. Argent Trust Co now owns 23,594 shares of the company’s stock valued at $1,145,000 after purchasing an additional 2,478 shares in the last quarter. 14.04% of the stock is owned by hedge funds and other institutional investors.

Sanofi Stock Up 2.7 %

NASDAQ SNY opened at $50.70 on Friday. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The business’s fifty day simple moving average is $48.49 and its 200-day simple moving average is $52.09. The firm has a market cap of $128.66 billion, a PE ratio of 25.86, a P/E/G ratio of 1.17 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last posted its earnings results on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, beating the consensus estimate of $0.22 by $1.35. The company had revenue of $13.44 billion for the quarter, compared to analyst estimates of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Sanofi’s revenue was up 12.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.55 EPS. As a group, equities analysts anticipate that Sanofi will post 3.94 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.